Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jul 6, 2017
Insider Transaction Report
Form 4
GALLIKER STEPHEN S
Director
Transactions
- Award
Common Stock
2017-07-06$0.59/sh+8,809$5,197→ 22,225 total - Award
Stock Option (right to buy)
2017-06-08+5,000→ 5,000 totalExercise: $0.55Exp: 2027-06-08→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]Effective January 1, 2017, 33% of the cash retainer payments to our Board will be pain in unrestricted shares of the Company's common stock delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter.
- [F2]Represents the closing stock price of the Company's stock on the first trading day of the quarter.
- [F3]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F4]This stock option will vest and become exercisable in equal quarterly installments over one year beginning three months from June 8, 2017, such that the option will be fully exercisable as of June 8, 2018.